Updated on 2025/06/20

Information

 

写真a

 
HAYASHI CHIKAKO
 
Organization
Faculty of Dental Science Department of Dental Science Assistant Professor
Graduate School of Dental Science Department of Dental Science(Concurrent)
Graduate School of Dental Science (Concurrent)
School of Dentistry Department of Dentistry(Concurrent)
Title
Assistant Professor
Profile
[Research activities] ・The research about the development of periodontal disease treatment using microRNA ・The research of the relationship between endoplasmic reticulum stress and diabetic periodontitis [Educational activities] ・The Lecture on periodontology for fourth-year dental students ・The guidance on basic clinical training, pre-clinical training, and clinical training guidance for 5th-year dental students ・The guidance for sixth-year dental students during clinical training [Medical activities] ・Dental treatment with a focus on periodontal disease treatment at Kyushu University
Homepage

Research Areas

  • Life Science / Conservative dentistry

Degree

  • Ph.D.(Kyushu University, Japan)

Research History

  • Kyushu University Faculty of Dental Science Department of Dental Science  Assistant Professor 

    2023.8 - Present

Research Interests・Research Keywords

  • Research theme: Development of miRNA therapy for periodontal disease-type 2 diabetes linkage mediated by endoplasmic reticulum stress

    Keyword: microRNA, type 2 diabetes, periodontitis

    Research period: 2024.4 - 2026.3

  • Research theme: Development of a method to control exacerbation of type2 diabetes promoted periodontal disease via endoplasmic reticulum stress

    Keyword: Endoplasmic reticulum stress, Type2 diabetes, Periodontitis

    Research period: 2023.9 - 2025.3

Awards

  • 2022年度日本歯周病学会奨励賞

    2023.5   日本歯周病学会   歯周病学の発展に寄与する学術論文を発表した若手研究者に対する受賞。

     More details

    miR-1260bの歯周炎骨吸収抑制効果及び小胞体ストレスを介した破骨細胞分化の制御を明らかにし、その成果はインパクトの高い学術雑誌(IF=5.5)に掲載された。また、これらの研究業績が認められ、3度の学会発表受賞を果たしている。これらの成果から歯周病学への発展が認められ、本賞を受賞した。

  • 令和4年度藤野賞

    2023.3   九州大学歯学府   大学院博士課程における研究活動(学会発表、論文)に対する表彰

  • The 108th Annual Meeting of the American Academy of Periodontology JSP/JACP Excellent Poster Award

    2022.11   the American Academy of Periodontology in collaboration with the Japanese Academy of Clinical Periodontology, and the Japanese Society of Periodontology   日本歯周病学会・日本臨床歯周病学会共催アメリカ歯周病学会における優れたポスター発表に対する受賞。

  • 第8回Young Investigator Award

    2022.9   日本歯周病学会   日本歯周病学会で優れた歯周病関連研究をした若手研究者に対する受賞。

  • 第155回日本歯科保存学会2021年度秋季学術大会カボデンタル優秀ポスター賞

    2021.11   日本歯科保存学会   歯科保存治療の再生治療分野での研究発表に対する受賞。

Papers

  • miR-1260b inhibits periodontal bone loss by targeting ATF6β mediated regulation of ER stress Reviewed International journal

    Chikako Hayashi, Takao Fukuda, Kentaro Kawakami, Masaaki Toyoda, Yuki Nakao, Yukari Watanabe, Takanori Shinjo, Tomomi Sano, Misaki Iwashita, Karen Yotsumoto, Miyu Shida, Takaharu Taketomi, Terukazu Sanui, Takeshi Uchiumi, Takashi Kanematsu, Fusanori Nishimura

    Frontiers in cell and developmental biology   10   1061216   2022.11   ISSN:2296-634X eISSN:2296634X

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media SA  

    The expression profiles of exosomal microRNAs (miRNAs) are regulated by the microenvironment, and appropriate priming with mesenchymal stem cells (MSCs) is one of the strategies to enhance the paracrine potency of MSCs. Our previous work demonstrated that exosomes from tumor necrosis factor (TNF)-α-primed human gingiva-derived MSCs (GMSCs) could be a therapeutic tool against periodontitis, and that TNFα-inducible exosomal miR-1260b is essential for the inhibition of alveolar bone loss. However, the precise molecular mechanism underlying miR-1260b-mediated inhibition of osteoclastogenesis is not yet fully understood. Here, we found that the activating transcription factor (ATF)-6β, a novel miR-1260b-targeting gene, is critical for the regulation of osteoclastogenesis under endoplasmic reticulum (ER) stress. An experimental periodontal mouse model demonstrated that induction of ER stress was accompanied by enhanced ATF6β expression, and local administration of miR-1260b and ATF6β siRNA using polyethylenimine nanoparticles (PEI-NPs) significantly suppressed the periodontal bone resorption. In periodontal ligament (PDL) cells, the ER stress inducer, tunicamycin, enhanced the expression of the receptor activator of NF-κB ligand (RANKL), while miR-1260b-mediated downregulation of ATF6β caused RANKL inhibition. Furthermore, the secretome from miR-1260b/ATF6β-axis-activated PDL cells inhibited osteoclastogenesis in human CD14^+ peripheral blood-derived monocytes. These results indicate that the miR-1260b/ATF6β axis mediates the regulation of ER stress, which may be used as a novel therapeutic strategy to treat periodontal disease.

    DOI: 10.3389/fcell.2022.1061216

    Scopus

    PubMed

    CiNii Research

    Other Link: https://www.frontiersin.org/articles/10.3389/fcell.2022.1061216/full

    Repository Public URL: https://hdl.handle.net/2324/7177891

  • Extracellular vesicles derived from GMSCs stimulated with TNF-α and IFN-α promote M2 macrophage polarization via enhanced CD73 and CD5L expression Reviewed International journal

    Yukari Watanabe, Takao Fukuda, Chikako Hayashi, Yuki Nakao, Masaaki Toyoda, Kentaro Kawakami, Takanori Shinjo, Misaki Iwashita, Hiroaki Yamato, Karen Yotsumoto, Takaharu Taketomi, Takeshi Uchiumi, Terukazu Sanui, Fusanori Nishimura

    Scientific reports   2022.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Repository Public URL: https://hdl.handle.net/2324/7161506

  • Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss ( vol 122, pg 306, 2021)

    Nakao, Y; Fukuda, T; Zhang, QZ; Sanui, T; Shinjo, T; Kou, XX; Chen, CD; Liu, DW; Watanabe, Y; Hayashi, C; Yamato, H; Yotsumoto, K; Tanaka, U; Taketomi, T; Uchiumi, T; Le, AD; Shi, ST; Nishimura, F

    ACTA BIOMATERIALIA   191   428 - 429   2025.1   ISSN:1742-7061 eISSN:1878-7568

     More details

    Language:English   Publisher:Acta Biomaterialia  

    The authors regret to report that a duplicate image was published in Fig. 3D. The image of Exo-TNF Day 0 was the same as PBS Day 5. Below is a corrected full Fig. 3 with the original figure caption. This error does not affect the results of Fig. 3 or the conclusions of the study. The authors sincerely apologize for any inconvenience caused.

    DOI: 10.1016/j.actbio.2024.11.029

    Web of Science

    Scopus

    PubMed

  • Luteolin, chemical feature and potential use for oral disease

    Fukuda T., Kawakami K., Toyoda M., Hayashi C., Sanui T., Uchiumi T.

    Current Oral Health Reports   11 ( 4 )   290 - 296   2024.12

     More details

    Publisher:Current Oral Health Reports  

    Purpose of Review: Luteolin, a natural polyphenolic flavone, is a bioactive compound with high thermal stability. Owing to its prominent antioxidant activity, luteolin has been reported to exert therapeutic effects on inflammation-associated diseases. This review discusses the therapeutic potential of luteolin for treating dental diseases. Recent Findings: Luteolin has multifaceted pharmacological activities, including anti-inflammatory, neuroprotective, anticancer, and cardioprotective effects. Furthermore, the antibacterial effects of luteolin are accompanied by an anti-biofilm effect. More recently, luteolin has been identified as an inhibitor of protein kinase R (PKR), which plays an essential role in inflammasome activation. In this regard, we demonstrated the potential of luteolin as a pulp sedation compound for pulpitis that acts by suppressing PKR-mediated inflammation in dental pulp cells. Summary: Although conventional dental treatments for dental caries or periodontitis largely depend on cause-related therapy, disruption of biofilms and regulation of inflammation are prerequisites for a favorable prognosis. Together with its superior anti-inflammatory and antibacterial effects, the biocompatible features of luteolin make it a promising candidate for treating dental diseases with fewer side effects.

    DOI: 10.1007/s40496-024-00389-w

    Scopus

  • Scaffold-free bone-like 3D structure established through osteogenic differentiation from human gingiva-derived stem cells Reviewed International journal

    Masaaki Toyoda, Takao Fukuda, Ryota Fujimoto, Kentaro Kawakami, Chikako Hayashi, Yuki Nakao, Yukari Watanabe, Tsukasa Aoki, Miyu Shida, Terukazu Sanui, Masahide Taguchi, Kensuke Yamamichi, Ayami Okabe, Tatsunori Okada Kyoko Oka, Koichi Nakayama , Fusanori Nishimura, Shunichi Kajioka

    Biochemistry and biophysics reports   38   101656   2024.2   ISSN:2405-5808

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Biochemistry and Biophysics Reports  

    Introduction & objectives: Stem cell therapy for regenerative medicine has been sincerely investigated, but not still popular although some clinical trials show hopeful results. This therapy is suggested to be a representative candidate such as bone defect due to the accident, iatrogenic resection oncological tumor, congenital disease, and severe periodontitis in oral region. Recently, the Bio-3D printer “Regenova®” has been introduced as an innovative three-dimensional culture system, equipped scaffold-free bio-assembling techniques without any biomaterials. Therefore, we expected a mount of bone defect could be repaired by the structure established from this Bio-3D printer using osteogenic potential stem cells. Material & methods: The gingival tissue (1x1 mm) was removed from the distal part of the lower wisdom tooth of the patients who agreed our study. Human Gingival Mesenchymal Stem Cells (hGMSCs) were isolated from this tissue and cultured, since we confirmed the characteristics such as facile isolation and accelerated proliferation, further, strong potential of osteogenic-differentiation. Spheroids were formed using hGMSC in 96-well plates designed for low cell adhesion. The size of the spheroids was measured, and fluorescent immunostaining was employed to verify the expression of stem cell and apoptosis marker, and extracellular matrix. Following four weeks of bone differentiation, μCT imaging was performed. Calcification was confirmed by alizarin red and von Kossa staining. Fluorescent immunostaining was utilized to assess the expression of markers indicative of advanced bone differentiation. Results: We have established and confirmed the spheroids (∼600 μm in diameter) constructed from human GMSCs (hGMSCs) still maintain stem cell potentials and osteogenic differentiation abilities from the results that CD73 and not CD34 were expressed as stem cell positive and negative marker, respectively. These spheroids were pilled up like cylindal shape to the “Kenzan” platform of Bio-3D printer and cultured for 7days. The cylindal structure originated from compound spheroids were tried to differentiate into bone four weeks with osteogenic induction medium. The calcification of bio-3D printed bone-like structures was confirmed by alizarin red and Von Kossa staining. In addition, μCT analysis revealed that the HU (Hounsfield Unit) of the calcified structures was almost identical to that of trabecular bone. Immunofluorescent staining detected osteocalcin expression, a late-stage bone differentiation marker. Conclusion: For the first time, we have achieved the construction of a scaffold-free, bone-like luminal structure through the assembly of spheroids comprised of this hGMSCs. This success is sure to be close to the induction of clinical application against regenerative medicine especially for bone defect disease.

    DOI: 10.1016/j.bbrep.2024.101656

    Web of Science

    Scopus

    PubMed

    Other Link: https://www.sciencedirect.com/science/article/pii/S2405580824000207?via%3Dihub

    Repository Public URL: https://hdl.handle.net/2324/7174370

  • Luteolin Is a Potential Immunomodulating Natural Compound against Pulpal Inflammation Reviewed International journal

    Kentaro Kawakami, Takao Fukuda, Masaaki Toyoda, Yuki Nakao, Chikako Hayashi, Yukari Watanabe, Tsukasa Aoki, Takanori Shinjo, Misaki Iwashita, Akiko Yamashita, Miyu Shida, Terukazu Sanui, Takeshi Uchiumi, Fusanori Nishimura

    BioMed research international   2024   8864513   2024.1   ISSN:23146133 eISSN:23146141

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Hindawi  

    Aim. The present study evaluated the therapeutic effects of luteolin in alleviating pulpitis of dental pulp- (DP-) derived microvesicles (MVs) via the inhibition of protein kinase R- (PKR-) mediated inflammation. Methodology. Proteomic analysis of immortalized human dental pulp (DP-1) cell-derived MVs was performed to identify PKR-associated molecules. The effect of luteolin on PKR phosphorylation in DP-1 cells and the expression of tumor necrosis factor-α (TNF-α) in THP-1 macrophage-like cells were validated. The effect of luteolin on cell proliferation was compared with that of chemical PKR inhibitors (C16 and 2-AP) and the unique commercially available sedative guaiacol-parachlorophenol. In the dog experimental pulpitis model, the pulps were treated with (1) saline, (2) guaiacol-parachlorophenol, and (3) luteolin. Sixteen teeth from four dogs were extracted, and the pulp tissues were analyzed using hematoxylin and eosin staining. Immunohistochemical staining was performed to analyze the expression of phosphorylated PKR (pPKR), myeloperoxidase (MPO), and CD68. Experimental endodontic-periodontal complex lesions were established in mouse molar through a silk ligature and simultaneous MV injection. MVs were prepared from DP-1 cells with or without pretreatment with 2-AP or luteolin. A three-dimensional microcomputed tomography analysis was performed on day 7 (n=6). Periodontal bone resorption volumes were calculated for each group (nonligated–ligated), and the ratio of bone volume to tissue volume was measured. Results. Proteomic analysis identified an endogenous PKR activator, and a protein activator of interferon-induced PKR, also known as PACT, was included in MVs. Luteolin inhibited the expressions of pPKR in DP-1 cells and TNF-α in THP-1 cells with the lowest suppression of cell proliferation. In the dog model of experimental pulpitis, luteolin treatment suppressed the expression of pPKR-, MPO-, and CD68-positive cells in pulp tissues, whereas guaiacol-parachlorophenol treatment caused coagulative necrosis and disruption. In a mouse model of endodontic-periodontal complex lesions, luteolin treatment significantly decreased MV-induced alveolar bone resorption. Conclusion. Luteolin is an effective and safe compound that inhibits PKR activation in DP-derived MVs, enabling pulp preservation.

    DOI: 10.1155/2024/8864513

    Web of Science

    Scopus

    PubMed

    CiNii Research

    Other Link: https://www.hindawi.com/journals/bmri/2024/8864513/

    Repository Public URL: https://hdl.handle.net/2324/7177888

  • miR-1260b inhibits periodontal bone loss by targeting ATF6β mediated regulation of ER stress

    Hayashi, C; Fukuda, T; Kawakami, K; Toyoda, M; Nakao, Y; Watanabe, Y; Shinjo, T; Sano, T; Iwashita, M; Yotsumoto, K; Shida, M; Taketomi, T; Sanui, T; Uchiumi, T; Kanematsu, T; Nishimura, F

    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY   10   2022.11   ISSN:2296-634X

  • Extracellular vesicles derived from GMSCs stimulated with TNF-α and IFN-α promote M2 macrophage polarization via enhanced CD73 and CD5L expression

    Watanabe Yukari, Fukuda Takao, Hayashi Chikako, Nakao Yuki, Toyoda Masaaki, Kawakami Kentaro, Shinjo Takanori, Iwashita Misaki, Yamato Hiroaki, Yotsumoto Karen, Taketomi Takaharu, Uchiumi Takeshi, Sanui Terukazu, Nishimura Fusanori

    Scientific Reports   12 ( 1 )   13344   2022.8   ISSN:2045-2322 eISSN:20452322

     More details

    Language:English   Publisher:Springer  

    Immunoregulatory properties of mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) are promising. Gingival tissue-derived MSCs (GMSCs) have unique immunoregulatory capacity and secrete large amounts of EVs. Recent findings suggest that priming MSCs with inflammatory stimuli is an effective strategy for cell-free therapy. However, the precise mechanism by which the contents of EVs are customized has not been fully elucidated. Here, we show that EVs derived from GMSCs primed with a combination of two pro-inflammatory cytokines, tumor necrosis factor-α (TNF-α) and interferon-α (IFN-α), synergistically promote anti-inflammatory M2 macrophage polarization by increasing the expression of cluster of differentiation 73 (CD73) and CD5 molecule-like (CD5L). Expression of CD73 by TNF-α/IFN-α stimulation was transcriptionally upregulated by the activation of mammalian target of rapamycin signaling and nuclear translocation of hypoxia-inducible factor 1α in GMSCs. TNF-α/IFN-α treatment also significantly increased the expression of CD5L mRNA via the transcription factor DNA-binding protein inhibitor ID3 and liver X receptor. Interestingly, exosomal CD5L is a prerequisite for the synergistic effect of EVs-mediated M2 macrophage polarization. These results indicate that combined pre-licensing with TNF-α and IFN-α in GMSCs is ideal for enhancing the anti-inflammatory function of EVs, which contributes to the establishment of a therapeutic tool.

    DOI: 10.1038/s41598-022-17692-0

    Web of Science

    Scopus

    PubMed

    CiNii Research

  • Combined application of geranylgeranylacetone and amelogenin promotes angiogenesis and wound healing in human periodontal ligament cells Reviewed International journal

    Hiroaki Yamato, Terukazu Sanui, Karen Yotsumoto, Yuki Nakao, Yukari Watanabe, Chikako Hayashi, Ryosuke Aihara, Misaki Iwashita, Urara Tanaka, Takaharu Taketomi, Takao Fukuda, Fusanori Nishimura

    Journal of cellular biochemistry   122 ( 7 )   716 - 730   2021.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/jcb.29903

    Repository Public URL: https://hdl.handle.net/2324/7218279

  • Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss Reviewed International journal

    Yuki Nakao, Takao Fukuda, Qunzhou Zhang, Terukazu Sanui, Takanori Shinjo, Xiaoxing Kou, Chider Chen, Dawei Liu, Yukari Watanabe, Chikako Hayashi, Hiroaki Yamato, Karen Yotsumoto, Urara Tanaka, Takaharu Taketomi, Takeshi Uchiumi, Anh D Le, Songtao Shi, Fusanori Nishimura

    Acta biomaterialia   ( 122 )   306 - 324   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.actbio.2020.12.046

    Repository Public URL: https://hdl.handle.net/2324/7218280

  • Amelogenin Downregulates Interferon Gamma-Induced Major Histocompatibility Complex Class II Expression Through Suppression of Euchromatin Formation in the Class II Transactivator Promoter IV Region in Macrophages Reviewed International journal

    Karen Yotsumoto, Terukazu Sanui, Urara Tanaka, Hiroaki Yamato, Rehab Alshargabi, Takanori Shinjo, Yuki Nakao, Yukari Watanabe, Chikako Hayashi, Takaharu Taketomi, Takao Fukuda, Fusanori Nishimura

    Frontiers in immunology   11   709   2020.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3389/fimmu.2020.00709

    Repository Public URL: https://hdl.handle.net/2324/7178811

▼display all

Presentations

▼display all

MISC

  • Correction to: Luteolin, chemical feature and potential use for oral disease (Current Oral Health Reports, (2024), 11, 4, (290-296), 10.1007/s40496-024-00389-w)

    Fukuda T., Kawakami K., Toyoda M., Hayashi C., Sanui T., Uchiumi T.

    Current Oral Health Reports   12 ( 1 )   2025.12

     More details

    Publisher:Current Oral Health Reports  

    The article Luteolin, chemical feature and potential use for oral disease, written by Takao Fukuda, Kentaro Kawakami, Masaaki Toyoda, Chikako Hayashi, Terukazu Sanui, Takeshi Uchiumi, was originally published Online First without Open Access. After publication in volume 11, issue 4, page 290 - 296 the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2024 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. The original article has been corrected.

    DOI: 10.1007/s40496-025-00398-3

    Scopus

Professional Memberships

  • JAPANESE SOCIETY OF PERIODONTOLOGY

  • The Japanese Society of Conservative Dentistry

Research Projects

  • 小胞体ストレスを介した歯周病-2型糖尿病連関に対するmiRNA治療法の開発

    Grant number:24K19899  2024 - 2025

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Early-Career Scientists

    林 千華子

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

    先行研究では、miR-1260bが、小胞体(ER)ストレス応答蛋白であるATF6βの発現制御を介して歯槽骨吸収抑制効果を示すことを明らかにした。ERストレスは歯周炎と糖尿病の両者の病態を負に修飾することが報告されている。さらに、2型糖尿病マウスの血中miRNAと腸内細菌叢に相関を示唆する報告もある。そこで、①ATF6βの2型糖尿病患者における歯周炎増悪への関与を検討し、②miR-1260bを用いたERストレス制御を介した糖尿病性歯周炎への効果検証を行うこととした。さらに、③miR-1260bによるインスリン抵抗性改善効果について、その機序を腸内細菌叢に着目し検証を行う。

    CiNii Research

  • 小胞体ストレスを介した2型糖尿病による歯周病の増悪制御法の開発

    Grant number:23K19722  2023 - 2024

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Research Activity start-up

    林 千華子

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

    2型糖尿病患者は、歯周炎の発症率や進行度が高く治療に抵抗性である。先行研究では、miR-1260bが小胞体(ER)ストレス応答蛋白であるATF6βの発現制御 を介して歯槽骨吸収抑制効果を示すことを世界に先駆けて発見した。歯周炎モデルマウスではERストレスが誘導されるが、2型糖尿病の原因である肥満もERストレスを誘導し、インスリン抵抗性を惹起する。しかし、ATF6βがインスリン抵抗性を介して歯周炎の病態に影響を及ぼすか否かは不明である。
    <BR>
    本研究では、①ATF6βの2型糖尿病患者における歯周炎増悪への関与を検討し、②miR-1260bのERストレス制御による2型糖尿病性歯周炎への治癒効果を検証する。

    CiNii Research

Educational Activities

  • 【九州大学歯学部】
    4年生:歯周病学1の講義
    5年生:臨床予備実習および臨床実習における指導
    6年生:臨床実習における指導

Class subject

  • 歯科臨床実習

    2025.4 - 2025.9  

  • 歯周病学2

    2025.4 - 2025.9  

  • 歯周病学1

    2024.10 - 2025.3  

  • 歯科臨床実習

    2024.4 - 2024.9   First semester

  • 歯周病学2

    2024.4 - 2024.9   First semester

  • 歯科臨床実習

    2023.10 - 2024.3   Second semester

  • 歯周病学1

    2023.10 - 2024.3   Second semester

▼display all

FD Participation

  • 2024.4   Role:Participation   Title:令和6年度 第1回全学FD(新任教員の研修)The 1st All-University FD (training for new faculty members) in FY2024

    Organizer:University-wide

  • 2023.8   Role:Participation   Title:令和5年度4部局合同男女共同参画FD

    Organizer:University-wide

Specialized clinical area

  • Biology / Medicine, Dentistry and Pharmacy / Dentistry / Periodontal Dentistry

Year of medical license acquisition

  • 2018